Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA
Biomarkers are the key to personalized treatment in patients with breast cancer. While tissue biomarkers are most useful in determining prognosis and upfront predicting response to therapy, circulating protein biomarkers such as CA 15-3 and carcinoembryonic antigen are mainly used in monitoring resp...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2018-05-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428318776169 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|